ABBV
AbbVie Inc.
Stock
$266.28+1.94 (+0.73%)Close Sep 28, 2026
ABBV's revenue for 2025 was $61.16 billion, up 8.6% from the year before.
From SEC filings, Latest filing: 10-Q, Aug 3, 2026
| Revenue (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $64.39B | +10.4% | 6.0% | 10.3% |
| Revenue (TTM) | $64.39B |
|---|---|
| YoY | +10.4% |
| 5-year CAGR | 6.0% |
| 10-year CAGR | 10.3% |
Revenue
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $61.2B | +8.6% |
| 2024 | $56.3B | +3.7% |
| 2023 | $54.3B | −6.4% |
| 2022 | $58.1B | +3.3% |
| 2021 | $56.2B | +22.7% |
| 2020 | $45.8B | +37.7% |
| 2019 | $33.3B | +1.6% |
| 2018 | $32.8B | +16.1% |
| 2017 | $28.2B | +10.1% |
| 2016 | $25.6B | +12.2% |
| 2015 | $22.9B | +14.5% |
| 2014 | $20.0B | +6.2% |
| 2013 | $18.8B | +2.2% |
| 2012 | $18.4B | +5.4% |
| 2011 | $17.4B | — |